Suppr超能文献

相似文献

1
TRIF, and TRIF-interacting TLRs differentially modulate several adenovirus vector-induced immune responses.
J Innate Immun. 2009;1(4):376-88. doi: 10.1159/000207194. Epub 2009 Mar 4.
2
TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells.
J Autoimmun. 2018 Sep;93:57-65. doi: 10.1016/j.jaut.2018.06.003. Epub 2018 Jun 28.
3
Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
Am J Physiol Heart Circ Physiol. 2019 May 1;316(5):H1027-H1038. doi: 10.1152/ajpheart.00697.2018. Epub 2019 Feb 22.
4
Differential requirements of MyD88 and TRIF pathways in TLR4-mediated immune responses in murine B cells.
Immunol Lett. 2015 Jan;163(1):22-31. doi: 10.1016/j.imlet.2014.11.012. Epub 2014 Nov 22.
6
WDFY1 mediates TLR3/4 signaling by recruiting TRIF.
EMBO Rep. 2015 Apr;16(4):447-55. doi: 10.15252/embr.201439637. Epub 2015 Mar 3.
7
TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
Eur J Immunol. 2010 Nov;40(11):3150-60. doi: 10.1002/eji.201040547. Epub 2010 Oct 19.
8
TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15.
J Immunol. 2013 Mar 1;190(5):2217-28. doi: 10.4049/jimmunol.1201630. Epub 2013 Jan 30.

引用本文的文献

1
Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses.
J Microbiol. 2024 Jul;62(7):491-509. doi: 10.1007/s12275-024-00159-4. Epub 2024 Jul 22.
2
Two Novel Adenovirus Vectors Mediated Differential Antibody Responses via Interferon-α and Natural Killer Cells.
Microbiol Spectr. 2023 Aug 17;11(4):e0088023. doi: 10.1128/spectrum.00880-23. Epub 2023 Jun 22.
3
Adenovirus vector-based vaccine for infectious diseases.
Drug Metab Pharmacokinet. 2022 Feb;42:100432. doi: 10.1016/j.dmpk.2021.100432. Epub 2021 Nov 12.
4
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines.
NPJ Vaccines. 2021 Oct 28;6(1):127. doi: 10.1038/s41541-021-00391-8.
5
Adenoviral vector-based platforms for developing effective vaccines to combat respiratory viral infections.
Clin Transl Immunology. 2021 Oct 12;10(10):e1345. doi: 10.1002/cti2.1345. eCollection 2021.
7
Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses.
Front Immunol. 2021 Jan 29;11:607333. doi: 10.3389/fimmu.2020.607333. eCollection 2020.
8
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines.
Front Immunol. 2020 May 19;11:909. doi: 10.3389/fimmu.2020.00909. eCollection 2020.
9
Rhoptry antigens as vaccine target.
Clin Exp Vaccine Res. 2019 Jan;8(1):4-26. doi: 10.7774/cevr.2019.8.1.4. Epub 2019 Jan 31.
10
Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.
Biomedicines. 2014 Apr 2;2(2):132-148. doi: 10.3390/biomedicines2020132.

本文引用的文献

3
DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profiles.
J Virol. 2008 Aug;82(16):8161-71. doi: 10.1128/JVI.00620-08. Epub 2008 Jun 4.
7
Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors.
Hum Gene Ther. 2007 Aug;18(8):753-62. doi: 10.1089/hum.2007.016.
8
Cutting edge: TLR2 directly triggers Th1 effector functions.
J Immunol. 2007 Jun 1;178(11):6715-9. doi: 10.4049/jimmunol.178.11.6715.
9
Toll-like receptors and Type I interferons.
J Biol Chem. 2007 May 25;282(21):15319-23. doi: 10.1074/jbc.R700009200. Epub 2007 Mar 29.
10
Type I IFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirus.
J Immunol. 2007 Mar 15;178(6):3505-10. doi: 10.4049/jimmunol.178.6.3505.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验